Skip to main content

Court Urged to Reinstate Dismissed Paraquat Bellwether Cases

Court Urged to Reinstate Dismissed Paraquat Bellwether Cases

Court Urged to Reinstate Dismissed Paraquat Bellwether Cases

Introduction

The Seventh Circuit Court of Appeals is considering whether to reinstate four Paraquat lawsuits that were previously dismissed.

These cases were originally selected for the first federal bellwether trials to examine potential links between the weedkiller and Parkinson’s disease. However, the trial judge dismissed them last year after barring the plaintiffs’ expert witnesses from testifying.

Background of Paraquat Litigation

These lawsuits are part of a broader legal battle against Syngenta and Chevron, with over 5,800 product liability claims filed in federal court. Plaintiffs allege that the manufacturers failed to warn users about the increased risk of Parkinson’s disease linked to Paraquat exposure. Since June 2021, the cases have been centralized in a multidistrict litigation (MDL) in the Southern District of Illinois to streamline pretrial proceedings and prepare representative cases for bellwether trials.

Dismissal of Bellwether Cases and Appeal

Despite the judge’s initial selection of bellwether cases, the first group was dismissed after expert testimony was excluded. This left the plaintiffs unable to prove that their Parkinson’s disease resulted from Paraquat exposure. The plaintiffs appealed the decision, arguing that their experts were unfairly held to an excessively high standard and that the ruling was premature. They claim the judge’s assessment of their testimony exceeded legal precedents and that a jury should have determined the reliability of the evidence.

Defendants’ Position

Syngenta and Chevron continue to deny the allegations, asserting that no peer-reviewed research has definitively linked Paraquat to Parkinson’s disease. They maintain that the plaintiffs’ claims lack scientific support and should be dismissed.

New Bellwether Cases Moving Forward

While the appeal is pending, the judge overseeing the MDL has moved forward with a second batch of bellwether cases. In August 2024, 10 new cases were selected, and in January 2025, six of those cases were chosen for full case-specific discovery. Three cases are set for the first bellwether trial on October 14, 2025, while the remaining three will go to trial on April 6, 2026.

Potential Impact of Bellwether Trials

Although these bellwether trials will not have a binding effect on other cases, their outcomes will likely influence settlement negotiations. If plaintiffs win, Syngenta and Chevron may be pressured to offer settlements to avoid costly individual trials across the country. Conversely, if the defendants prevail, it could weaken the broader litigation efforts.

Significance of the Appeal’s Outcome

As the legal proceedings continue, the Seventh Circuit’s ruling on whether to reinstate the dismissed cases could significantly impact the direction of the Paraquat litigation. The decision may shape how courts handle expert witness testimony and determine the strength of similar claims in the future.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Tepezza Hearing Loss MDL: Bellwether Trials Set for 2026

Categories: Tepezza

A U.S. District Judge overseeing Tepezza hearing damage lawsuits nationwide has scheduled four bellwether trials for 2026. These trials are intended to help both parties assess how juries may respond to the evidence and testimonies that could be…

3M Moves to Dismiss 100+ Bair Hugger Infection Lawsuits

Categories: Bair Hugger System

Nearly a decade after litigation first began, 3M Company continues to face thousands of lawsuits over its Bair Hugger warming blankets, which have been linked to…

Bayer May Issue New Stock to Fund Roundup Settlements

Categories: Roundup

Bayer has announced plans to issue new shares to finance legal settlements and ongoing litigation costs related to Roundup.
The company is also contemplating withdrawing its…

🎁 March VIP Medical Record Review Offer – Get 300 Pages Free!          
Includes a Free Life Care Plan Report + 10% Off Future Reviews!

Only 7 spots left out of 15—first come, first served!